119 related articles for article (PubMed ID: 9566719)
1. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719
[TBL] [Abstract][Full Text] [Related]
2. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
[TBL] [Abstract][Full Text] [Related]
3. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.
Saegusa M; Okayasu I
Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
[TBL] [Abstract][Full Text] [Related]
7. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
8. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
10. CD44 variant exons in leukemia and lymphoma.
Akisik E; Bavbek S; Dalay N
Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
12. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
13. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
14. CD44 variant isoform expression and breast cancer prognosis.
Tokue Y; Matsumura Y; Katsumata N; Watanabe T; Tarin D; Kakizoe T
Jpn J Cancer Res; 1998 Mar; 89(3):283-90. PubMed ID: 9600122
[TBL] [Abstract][Full Text] [Related]
15. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
[TBL] [Abstract][Full Text] [Related]
16. Alternative exon-specific PCR method for the analysis of human CD44 isoform expression.
Lockhart MS; Gravisaco MJ; Mongini C; Waldner C; Alvarez E; Hajos SE
Oncol Rep; 1999; 6(1):219-24. PubMed ID: 9864432
[TBL] [Abstract][Full Text] [Related]
17. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma.
Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1217-23. PubMed ID: 11031408
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 variants and its association with survival in pancreatic cancer.
Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
[TBL] [Abstract][Full Text] [Related]
20. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
Yoshida K; Sugino T; Bolodeoku J; Warren BF; Goodison S; Woodman A; Toge T; Tahara E; Tarin D
J Clin Pathol; 1996 Apr; 49(4):300-5. PubMed ID: 8655705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
